Brief: Hamlet Pharma Q1 Pretax Loss Narrows To SEK 1.8 Mln
12/11/2020 07:38
Nov 12 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* Q1 NET SALES FOR Q1 TOTALED KSEK 0 (0)
* Q1 LOSS BEFORE TAX AMOUNTED TO KSEK -1,843 (-2,743)
Source text: https://bit.ly/36tzWFJ
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Hamlet BioPharma AB
See all newsBrief: Hamlet Biopharma Announces Completion Of Alpha1h Phase Ii Study In Non-Muscle Invasive Bladder Cancer
Brief: Hamlet Biopharma Holds Successful In Person Meeting With US FDA
Brief: Hamlet Pharma Q2 Loss Before Tax Narrows To SEK 2.8 Mln
Brief: Hamlet Pharma Gets Patent In Europe
Brief: Hamlet Pharma Gets Patent Granted In Europe